作者
Carolyn L. Rochester,Jennifer A. Alison,Brian Carlin,Alex R. Jenkins,Narelle S. Cox,Gerene Bauldoff,Surya P. Bhatt,Jean Bourbeau,Chris Burtin,P Camp,Thomas M. Cascino,Grace Anne Dorney Koppel,Chris Garvey,Roger Goldstein,Drew Harris,Linzy Houchen-Wolloff,Trina Limberg,Peter K. Lindenauer,Marilyn L. Moy,Christopher J. Ryerson,Sally Singh,Michael Steiner,Rachel S Tappan,A.M. Yohannes,Anne E. Holland
摘要
Background: Despite the known benefits of pulmonary rehabilitation (PR) for patients with chronic respiratory disease, this treatment is underused.Evidence-based guidelines should lead to greater knowledge of the proven benefits of PR, highlight the role of PR in evidence-based health care, and in turn foster referrals to and more effective delivery of PR for people with chronic respiratory disease.Methods: The multidisciplinary panel formulated six research questions addressing PR for specific patient groups (chronic obstructive pulmonary disease [COPD], interstitial lung disease, and pulmonary hypertension) and models for PR delivery (telerehabilitation, maintenance PR).Treatment effects were quantified using systematic reviews.The Grading of Recommendations, Assessment, Development and Evaluation approach was used to formulate clinical recommendations.Recommendations: The panel made the following judgments: strong recommendations for PR for adults with stable COPD (moderate-quality evidence) and after hospitalization for COPD exacerbation (moderate-quality evidence), strong recommendation for PR for adults with interstitial lung disease (moderate-quality evidence), conditional recommendation for PR for adults with pulmonary hypertension (low-quality evidence), strong recommendation for offering the choice of center-based PR or telerehabilitation for patients with chronic respiratory disease (moderate-quality evidence), and conditional recommendation for offering either supervised maintenance PR or usual care after initial PR for adults with COPD (low-quality evidence).Conclusions: These guidelines provide the basis for evidencebased delivery of PR for people with chronic respiratory disease.